Lymphoma waa kansar dhiig oo saameeya lymphocytes, nooc ka mid ah unugyada dhiigga cad. Labada nooc ee lymfoma waa Hodgkin's lymphoma iyo non-Hodgkin's lymphoma, ama NHL. Inkastoo lymphomas badanaa bilaabaan qanjidhada nudaha , waxay ku kici karaan meel kasta oo jidhka ah. Marka ay ka soo baxaan dibedda qanjidhada, waxaa loo yaqaannaa "extranodal lymphomas".
Lymphoma lymphoma waa lymfoma aan caadi ahayn . Marka lymphoma uu ka bilowdo meel ka baxsan qanjidhada nudaha, waxay aad ugu badan tahay kansarka si ay u bilaabaan mareenka caloosha iyo mindhicirka marka loo eego lafaha.
Guudmarka
Lymphoma lymphoma waa xaalad aad u dhif ah oo lymfoma ka bilaabanto lafaha. Xaaladdan waxay ku fadhidaa qiyaastii 1 ilaa 2 boqolkiiba dhammaan kiisaska non-Hodgkin lymphoma , oo leh xaalad sare oo ah 3 ilaa 9 boqolkiiba carruurta iyo dhallinyarada. Kansarrada ka billowda meel kale oo kadibna ku faafaan lafaha ayaa aad uga badan lymphoma lafta.
Yaa Saameeyaa ?
Lymphomas-ka laf-dhabarka waxay badanaa saameysaa dadka waaweyn. Dumarka waxay u badan tahay in ay saameeyaan dumarka. Inta badan waa non-Hodgkin lymphomas ee nooca weyn ee B-unuga , taas oo tirada kiisaska ay ku badan tahay inta u dhaxeysa da'da 45 iyo 60. Hase yeeshee, marka ay timaado hoose ee lafdhabarta ku dhaca maskaxda ama tailbone, lafaha hoose ee lafaha dhacdooyinka da'yarta iyo labaatan jir.
Xaalado dhif ah ayaa dhacaya carruurta leh da'da da'da 12 sano.
Astaamaha
Inta badan dadka ay saameeyeen laf-dhabarka hore waxay dareemaan xanuunka lafahooda. Badanaa xanuunku wuu dareemaa xitaa nasasho. Tani waxay sii socon kartaa bilo kahor inta aan calaamado kale soo bixin. Marka lymphoma sii weynaado, waxay sababi kartaa barar xuddunta oo xaddido dhaqdhaqaaqa gacanta ama lugta.
Calaamadaha kale ee lymfoma sida qandho iyo miisaan lumis ma aha caan.
Baaritaanno
Sawireynta cudurka, raajada, iyo lafaha lafaha , waxay caawiyaan in la ogaado qanjidhada lafaha hoose. Burooyinka lafaha waxay muujinayaan isbeddellada muuqaalka ee muuqaalka lafaha ee MRI ama CT scans. Waxaa jiri kara hab aan caadi ahayn oo loo yaqaan 'moth-eaten pattern' oo lafo-beel ku dhacda meelaha ay saameeyeen lymphoma.
Si loo go'aamiyo nooca buro, dheecaanka lafaha ayaa la sameeyaa. Tani waxaa la samayn karaa qalliin, adigoo qaadanaya qayb yar oo ah lafaha ku-tumashada ee lafaha ee baaritaanka microscopic. Tijaabooyinka kale ayaa ka caawiya in la ogaado haddii buro ay ku badan tahay ama ay ku koobantahay lafta. PET / CT ee xabadka, caloosha iyo miskaha ayaa loo isticmaali karaa si loo ogaado heerka xajmiga ku jira qanjirada iyo joogitaanka cudurrada fog.
Noocyada
Inta badan, lymphoma waa lafo-la'aan lafdhabarta ah waa non-Hodgkin lymphoma ama NHL. Lymphoma lymphoma ee lafaha ayaa aad u yar. Noocyada kala duwan ee NHL, waxay kala qaybsamaan Lymphoma-ka weyn ama DLBCL, waa laf-dhabarka ugu badan ee lafaha. Nooca unugyada lymphoma ayaa hagi kara go'aanada ku saabsan nooca daaweynta ee la dabagalayo.
Daaweynta
Sababtoo ah lymphoma lafdhabarku waa mid aad u yar, hal hab oo daaweyn ah oo aan fiicnayn ayaa la sameeyay. Daawooyinka hadda jira waxay badanaa ka kooban yihiin kiimiko ku daweyn dhowr wareegyo oo lagu daro daaweynta shucaaca si lafta.
Daaweynta dhowr marxaladood oo kala duwan, ama daaweynta maaddo-dhaqameedka, ayaa caadi ah, hase yeeshee, isbeddelka shucaaca iyo kemotherabi ayaa ku kala duwan warar la daabacay. Heerarka ugu sarreysa ee lymphomas lafa ahaantoodu inta badan way ka fiican yihiin noocyada kale ee non-Hodgkin lymphoma.
Jaamacadda Miami ayaa sheegaysa in ka badan 80 boqolkiiba dadka lagu daweeyo lafaha hoose ee lafo-beelka ah iyada oo aan la sii wadi karin cudurkooda 4 sano kadib - waxay heleen 83 boqolkiiba noolaan la'aanta bilaashka ah, ama PFS ee daraasad ka kooban 53 bukaan. Looma arkin farqi u dhexeeya bukaanka lagu daaweeyo kiimoteraabiga ama chemotherapy oo lagu daray shucaac.
Si kastaba ha ahaatee, waxaa jiray isbeddel lagu sameeyay horumarinta PFS loogu talagalay bukaanada qaba DLBCL lagu daweeyo rituximab iyo daaweynta kiimikada.
Gabagabo
Daaweynta ka dib, baaritaannada PET / CT ayaa si gaar ah faa'iido u leh si loo qiimeeyo jawaabta daaweynta. Daraasada sawir-baadhista ka-dib-u-eegista ee xulashada waa baaritaanka PET / CT, taas oo ka caawisa kala-takooridda cudurka joogtada ah ee fibrosis. Bukaan-socodka waa in sidoo kale la kormeero dib-u-dhiska muddada dheer. Lymphoma laf-dhabarka ayaa leh hoos u dhac ku yimaada dib-u-dhac deg deg ah waxaana inta badan soo noqnoqda goobaha fog ee cudurka asalka ah.
Ilaha
Wixi dheeraad ah oo ku saabsan mawduucan, sahaminta ilaha soo socda:
Alencar A, Pitcher D, Byrne G, et al. Lymphoma lymphoma - waayo aragnimada jaamacada Miami. Leukemia iyo Lymphoma . 2010; 41 (1): 39-49.
Thornton E, Krajewski KM, O'Regan KN iyo al. Tilmaamaha muuqaalka kalluunka asaasiga ah iyo kan labaad ee maskaxda. Wargeyska Ingiriiska ee Radiology . 2012; 85 (1011): 279-284.
Sawirada Tumoraha Lafaha iyo Nabaro Tumor-Leh: Ciladaha iyo Codsiyada; A. Mark Davies, Murali Sundaram, Steven J. James. Daadinta Sayniska & Warbaahinta Ganacsiga, 2009.
Mabaadi'da iyo Tababarka Shucaac Oncology 4th Ed. Tifaftirayaasha: Carlos A Perez, Luther W Brady, Edward C Halperin, iyo Rupert K Schmidt-Ullrich. Lippincott Williams & Wilkins, 2003.
Beal K, Allen L, Yahalom J. Lymphoma Astaamaha: Natiijooyinka daaweynta iyo isirrada qiyaasta ah ee la socota muddada dheer ee dabagalka 82ka bukaan. Cancer , 2006; 106 (12).
O'Connor AR, Birchall JD, O'Connor SR iyo al. Qiimaha 99mTc-MDP oo ah lafo-mareenka laf-dhabarka aasaasiga ah ee lafaha. Isgaadhsiinta Nuucyada Nuucyada. 2007; 28 (7): 529-31.
Swerdlow SH, Campo E, Harris NL, et al, eds. Qoollada WHO Qaybaha Tumors ee Unugyada Haematopoietic iyo Lymphoid. 4aad ed. Geneva, Switzerland: IARC Press; 2008.